Is endometriosis a prenoplastic condition ? Prof. Dr. Fuat Demirkıran I.U Cerrahpaşa School of Medicine. Department of OB&GYN Division Of Gynocol Oncol.

Slides:



Advertisements
Similar presentations
Audit of Impact of NICE guidelines for Ovarian Cancer Helen Losty Royal United Hospital Bath 17th November 2011.
Advertisements

Uterine & Ovarian Cancer
Epidemiology of Gynaecological Cancers. General Overview On global basis cervical cancer is the most common pelvic malignancy in developing countries.
Cancer Epidemiology: The need for Global Information sharing in obesity and cancer ? Edinburgh, August 2011 Faina Linkov, PhD Research Assistant Professor.
Endometriosis and Cancer…Is there a Causal Link? Paula Payton Masters Project 2/22/06 Advisor: Prof Eileen VanDyke.
A significant increase in the incidence of endometrial cancer. This increased incidence of endometrial cancer has been widely interpreted to be a result.
OVARY 2 Neoplasms of the Ovary
Endometrial Cancer Nancy Wozniak, MD.
Endometrial Cancer Screening for Cancer in Women.
Uterine corpus. benign diseases: - endometritis - endometriosis and adenomyosis - endometrial polyps precursor lesions of endometrial carcinoma endometrial.
Endometrial Hyperplasia
Ji Young Lee, MD, PhD, David Marchetti, MD, M Steven Piver, MD Department of Obstetrics and Gynecology Sisters of Charity Hospital, Buffalo, NY The Clinical.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Malignant Ovarian Tumors
,, Presence of functioning endometrial glands and stroma outside their usual location ( the uterine cavity) ”.
Ovary.
22/10/1436. Addar Professor Gyneoncologist OB/GYN Dept. KKUH and College of Medicine MKing Saud University.
Ovarian Cancer Awareness In the Community. Facts about Ovarian Cancer 80% of cases occur in women over th most common cancer in women Almost 7000.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Endometrial Carcinoma Fuat Demirkıran, MD Istanbul University, Cerrahpaşa School Of Medicine, OB&GYN Department, Gyn Oncology.
Ovarian Cancer National Alliance Ovarian Cancer: What All Women Need to Know.
GYN ONCOLOGY OBesity Project. “Obesity is linked as a cause of 20% of cancer deaths in women.”
Dr Matt Hewitt Prophylactic Bilateral Salpingoophorectomy.
Post-menopausal bleeding PV Dr Nasira Sabiha Dawood.
Santa Monica 2006 IGCS - Interactive Session
Fallopian Tube and Ovarian Malignancy Schwartz's Principles of Surgery Chapter 41. Gynecology.
Conservative Management of Borderline Ovarian Tumor Prof. Dr. Fuat Demirkıran I.U Cerrahpaşa School of Medicine. Department of OB&GYN Division Of Gynocol.
Endometrial Carcinoma
Session Fertility and Pregnancy FL-BBM Specific questions Risk of premature ovarian failure Ability to become pregnant Safety of pregnancy.
Ovarian Cancer Tumour Markers Brig Dilshad Ahmed Khan MBBS, MCPS, FCPS, FRC Path, PhD Head of Chem Pathology & Endocrinology dept AFIP, Rawalpindi.
A role for lipids and statins in breast cancer risk and prevention? Dr. Mieke Van Hemelrijck Senior Lecturer in Cancer Epidemiology 3 August 2015.
Chapter 8 Cancer. Chapter overview Introduction Carcinogenesis Physical activity and colorectal cancer Physical activity and breast cancer Physical activity.
Breast/ovary.  A 32-year-old Caucasian female presents to your office with a breast mass found to be malignant on biopsy. Ten years ago, she was diagnosed.
Personal Risk Factors Gender being a woman is the main risk factor for developing breast cancer (100 times more common in women) Age occurrence increase.
Cancer When cell division goes wrong……. Growing out of control, cancer cells produce malignant tumors Cancer is a general term for many diseases in.
Dr. Saadeh Jaber OBGYN consultant Epidemiology Second most common gynecological cancer. >35, median 70 It accounts for deaths more than cancer of.
17 th century microscopes In The Name of God PARISA REZAEI,M.D.,AP.CP.
Breast Cancer Prevention Art or Science? Kristi McIntyre M.D. Texas Oncology 2005.
Low Fat Center for Energy Balance Journal Club Shannon Armbruster MD Gynecologic Oncology October 15, 2015.
 Definition ◦ It is combination of two Latin words ◦ Pathos meaning disease ◦ Logos meaning study Pathology is a branch of medicine that deals with the.
Understanding Cancer and Related Topics
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
UTERINE CORPUS. ACUTE ENDOMETRITIS Is most often related to intrauterine trauma from instrumentation, intrauterine contraceptive device or complications.
Javad Jamshidi Fasa University of Medical Sciences, December 2015 Cancer Genetics Session 4 Medical Genetics.
Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.
Endometrial polyp, hyperplasia, carcinoma Dr: Salah Ahmed.
Mark Browning, M.D. IUSME.  22,000 Cases  14,000 Deaths  Overall Survival Rate is 35%  Survival Rate Depends on Stage.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
SCREENING IN GYNECOLOGICAL CANCER Taravat Fakheri OB/GYN KUMS.
Sex-specific trends in lung cancer incidence and survival : a population study of cases 호흡기 내과 R3 조주희 Thorax 2011;66: Camilla M T Sagerup,
Targeting of reactive oxygen species can be a potential therapeutic strategy for cancer treatment Ying-Ray Lee 1, San-Yuan Chen 2, and Hau-Ren Chen 3 1.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Endometriosis *Is the presence of endometrial glands and stroma outside the endometrial cavity and walls *Deposits proliferate during the menstrual cycle,
Endometriosis & Cancer Association
Facilitator: Pawin Puapornpong
Ovulation Induction and Cancer
Dr. Amit Gupta Associate Professor Dept Of Surgery
Seromucinous Tumor of the Ovary
DISEASES OF THE OVARIES
Dr . Saadeh Jaber OBGYN consultant 2010
Amant F – Gynecological Oncology - UZ Gasthuisberg, Leuven
Male and Female Reproductive Health Concerns
Biomarkers of ovarian cancer and cysts
Biomarkers of ovarian cancer and cysts
Ovarian tumors Ali Al Khader, M.D. Faculty of Medicine
K. Lenhard Rudolph, Daniel Hartmann, Oliver G. Opitz  Gastroenterology 
Endometriosis and ovarian cancer: potential benefits and harms of screening and risk- reducing surgery  Sun-Wei Guo, M.Med., Ph.D.  Fertility and Sterility 
Pathogenesis of deep endometriosis
Management of endometriosis
Prophylactic Oophorectomy
Presentation transcript:

Is endometriosis a prenoplastic condition ? Prof. Dr. Fuat Demirkıran I.U Cerrahpaşa School of Medicine. Department of OB&GYN Division Of Gynocol Oncol Asian Con. on Endometriosis Nowember Istanbul

Endometriosis… to be present 10–15% of women in the reproductive age group.. 2–5% of postmenopausal women.. 25–30% of infertile women.. 40–70% of women with chronic pelvic pain..

starting with ectopic tissue implantation bleeding in this ectopic tisue Inflamation fibrin deposition, adhesion and scar formation distortion of peritoneal surfaces The natural course of endometriosis

The points of discussion here are to clarify whether endometriosis should be considered a precursor lesion of cancer such as, ovarian uterine and breast and if transformation to the cancer occurs frequently.

The relationships between endometriosis and cancer Malignant transformation of endometriosis occurs generally in % of cases. Ovarian cancer develops in 1–5% of cases with ovarian endometriosis and in a lower percentage of cases with extra-ovarian endometriosis. Endometriosis is present in 10 to 15% of patients with ovarian cancer.

The course of endometriosis Jian-Jun Wei and et al Int J Gyncol Patho 2011

Similar factors effect the incidence of ovarian cancer and endometriosis. Decreased risks tubal ligation hysterectomy oral contraceptives pregnancy Increased risks infertility early menarche, Late menopause Ovarian Cancer and Endometriosis

The relationship between endometriosis and ovarian cancer RR was 4 in primary infertil patients with endometriosis.

The relationship between endometriosis and ovarian cancer

In this study, dataset consisted of data from women. (7911 with invasive ovarian cancer, 1907 with borderline ovarian cancer, and controls) * No association was noted between a history of endometriosis and borderline ovarian cancer. * History of endometriosis was associated with an increased risk of invasive epithelial ovarian cancer. * 2-3 fold increase in the risk of clear-cell, low-grade serous, and endometrioid invasive ovarian cancer in patients with endometriosis.

Clinico-pathologic characteristics of ovarian cancer seen in patients having endometriosis …….tended to be younger to be diagnosed in earlier stages to be tumor with lower grade lesions to be better survival to be endometrioid and clear cell subtypes

The relation between endometriosis and other cancers such as breast, cervical and endometrial cancer

The relationship between endometriosis and breast cancer

The relationship between endometriosis and cervical cancer

The relationship between endometriosis and endometrial cancer

There is a relation between endometriosis and ovarian cancer, so. endometriosis increases the risk of ovarian cancer !!!

The weaknesses of the these studies Most of the cohorts consisted only of patients hospitalized for endometriosis. This could result in the inclusion of women with mainly moderate or severe disease and thereby lead to an overestimation of the risk of cancer among women with endometriosis. Limitation of the studies was the lack of information on possible confounding factors that might have influenced the results. In most of studies, there is no imformation about drug / hormon use, origin of endometriosis, fertility, parity and histologic verification of endometriosis.

It is often suggested that a relative risk of at least 2 is required before the conclusion that a risk estimate can be considered strong and, in particular, to be free of the influence of confounders and other sources of bias and selectivity. Relative risks of less than 2.0 may also be consistent with causality. Overall, the reported strength of association between endometriosis and ovarian cancer ranged between 1.3 and 4. Despite the weak association, majority of studies documented statistically significant association between endometriosis and ovarian cancer. Some studies found that the cancer risk markedly increased in women having a long-standing history of the disease. This finding suports the causal association. Causality between endometriosis and ovarian cancer - I

Causality between endometriosis and ovarian cancer - II endometroid or clear cell ovarian carcinoma

Histological, Genetic and Molecular Alterations in Endometriosis

Histological Alterations Atypical endometriosis as a precursor of malignancy

Of the 127 patients with ovarian ca, 37(29%) had histologic evidence of endometriosis. And 70% of clear cell ca. 43% of endometrioid ca, 7% of serous ca., and 0% of mucinous ca. had endometriozis In 37 cases with endometriosis, 78% showed atypical endometriosis The mean Ki-67 indices were as follows: ovarian carcinoma, 23.1; atypical endometriosis, 9.9; typical endometriosis, 2.7. Atypical endometriosis shows proliferation activity, suggesting it is a precancerous status. Gynecologic Oncology 77, 298–304 (2000)

Metaplasia (8.8–16.0) Hyperplasia 32 9,4 (6.5–13.1) Atypia 20 5,9(3.6–9.0) Endometrioid adenoca (2.3–6.9) Conclusions. Epithelial abnormalities are a common finding in cystic ovarian endometriosis.

Fukunaga M, Nomura K, Ishikawa E, Ushigome S. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology 1997;30:249–55. They reported that atypical endometriotic region were observed in 61% of 54 endometriosis associated ovarian cancers,but these changes (atypical glandular) were seen in only 1.7% of 255 endometriosis cases without cancers.

Retrospective analysis of 160 malignant and 23 borderline ovarian tumours during the period 1995– % of the ovarian ca tumours contained endometriosis. The incidence of ovarian endometriosis in borderline tumours was 13% compared to in ovarian cancer 6.9%. 57% of cases were classified as atypical endometriosis and 43% cases were typical endometriosis. Endometriosis observed in 22% of the endometrioid, 9% of clear cell ca and 10.8% of the mixed adeno adenoca

Atypical endometriosis are considered to be precancerous lesion. With these findings, it is considered that Atypical endometriosis may represent a transition from benign endometriosis to carcinoma.

Genetic alterations in endometriotic tissue I monoclonality of endometriosis…… % (in 7 studies) monoclonality of endometriosis…….. 6 % (in 1 study)

loss of heterozygosity (LOH) in endometriosis Genetic alterations in endometriotic tissue II commonly involving chromosomes 9p, 11q, and 22q.

P53 mutations PTEN mutations K-Ras mutations There are conflicting results Genetic alterations in endometriotic tissue III in 30% of endometriosis coexisting with Ovarian CCC in 10-20% of endometriotic associated ovarian Ca. in 20% of endometriotic cyst, in 20% of EC and in 8% of CCC

ARID1A mutations in endometriosis Genetic alterations in endometriotic tissue V ARID1A mutations were seen in 46% of endometriosis associated-ovarian clear-cell ca. 30% of endometriosis associated- ovarian endometrioid ca. 0% of endometriosis associated-high-grade serous ovarian ca. Wiegand et al. NEMJ 2010

Epigenetic variations in endometriosis Heme and free iron induced oxidative stress I nflammation Steroid hormones

The repetition of hemorrhage in the endometriotic cysts result in excess accumulation of heme and free iron in endometriotic lesions. Heme and free iron are pro-oxidant and can induce oxidative stress and DNA damage, possibly increasing the risk of some cancer. Inflammatory cells and cytokines in endometriosis may promote angiogenesis, cell proliferation, inhibition of apoptosis, and production of reactive oxygen species that may induce DNA damage and mutations. Thus, inflammation may contribute to tumor growth and progression. Some studies have demonstrated a local increase in estradiol concentration in endometriotic lesions. Estradiol stimulates cyclooxygenase-2 (COX-2). This can induce DNA damage.

Jian-Jun Wei and et al Int J Gyncol Patho 2011 Finaly, endometriosis-associated tumor progression may be related to many independent factors

In conclusion, the exact molecular mechanisms that may lead to malignant transformation of endometriosis are not completely understood. The potential etiology regarding the association between endometriosis and ovarian cancer seems to be multifactorial. Given the high prevalence of endometriosis and the high mortality of ovarian cancer, the potential association has important public health implications and

So, OB&GYNs should be aware of the apparently increased risk of ovarian cancer among endometriosis patients, and increased attention should particularly be paid to patients with early diagnosis, a long- standing history of disease and/or associated infertility,

Thank you